Bayer to Present New Finerenone and Asundexian Data
Bayer says it will present finerenone data across heart failure and chronic kidney disease, plus asundexian data from OCEANIC-STROKE.
Bayer says it will present finerenone data across heart failure and chronic kidney disease, plus asundexian data from OCEANIC-STROKE.